Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The Annals of Pharmacotherapy|March 29, 2002
Severe interaction between ritonavir and acenocoumarolJosep M Llibre, Joan Romeu, Estibaliz López, et al.
Clinical Rheumatology|May 6, 2014
Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patientsLourdes Mateo, Susana Holgado, Maria Luisa Mariñoso, et al.
AIDS Research and Human Retroviruses|January 15, 2005
Influence of prior structured treatment interruptions on the length of time without antiretroviral treatment in chronically HIV-infected subjectsJosé Moltó, Lidia Ruiz, Joan Romeu, et al.
AIDS (London, England)|February 14, 2006
The effect of atorvastatin treatment on HIV-1-infected patients interrupting antiretroviral therapyEugènia Negredo, Bonaventura Clotet, Jordi Puig, et al.
AIDS Research and Human Retroviruses|May 9, 2008
Drug-resistance mutations number and K70R or T215Y/F substitutions predict treatment resumption during guided treatment interruptionsLaila Darwich, Anna Esteve, Lidia Ruiz, et al.
The Open AIDS Journal|October 17, 2008
Fatal fast-evolution of nasopharyngeal squamous cell carcinoma in an HIV patient with EBV and HPV (-16 AND -33) in blood serumGuillem Sirera, Sebastià Videla, Joan Romeu, et al.
AIDS Research and Human Retroviruses|September 23, 2006
Naive CD4(+) T cells and recent thymic emigrant levels in treated individuals with HIV: clinical relevanceMargarita Bofill, Javier Martinez-Picado, Raul Ruiz-Hernandez, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 8, 2008
The magnitude of interferon-gamma responses to human cytomegalovirus is predictive for HIV-1 disease progressionLaila Darwich, Cecilia Cabrera, Joan Romeu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 2, 2002
Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimensCarmina R Fumaz, Albert Tuldrà, Ma José Ferrer, et al.
Leukemia & Lymphoma|April 11, 2003
Favorable impact of virological response to highly active antiretroviral therapy on survival in patients with AIDS-related lymphomaJosé-Tomás Navarro, Josep-María Ribera, Albert Oriol, et al.
Pageof 2